Table 2 Laboratory and radiographic findings of the hospitalized patients from the two outbreaks†.
Variable | Value | |
|---|---|---|
Xiangyang outbreak (n = 298) † | Jingmen outbreak (n = 42) | |
WBC count | ||
Median (range), 109 cells/liter | 10.4 (3.1–25) | 10.5 (3.4–15.4) |
>10 × 109 cells/L, no. (%) | 156 (52.3) | 21 (50.0) |
<4 × 109 cells/L, no. (%) | 23 (7.7) | 3 (7.1) |
RBC count, median (range), 1012 cells/liter | 4.46 (3.45–6.0) | 4.31 (3.47–4.97) |
Platelet count, median (range), 109 cells/liter | 213.2 (129–414) | 223.5 (137–414) |
Hemoglobin, median (range), g/liter | 133 (98–312) | 134 (102–156) |
Glucose, >6.2 mmol/liter, no. (%) | 76 (25.5) | 9 (21.4) |
Creatine Kinase, >200 U/liter, no. (%) | 97 (32.6) | 18 (42.9) |
Creatine kinase MB fraction, >25 U/liter, no. (%) | 85 (28.5) | 18 (42.9) |
Lactate dehydrogenase, >250 U/liter, no. (%) | 39 (13.1) | 5 (11.9) |
Aspartate aminotransferase, >40 U/liter, no. (%) | 43 (14.4) | 6 (14.3) |
Alanine aminotransferase, >40 U/liter, no. (%) | 41 (13.8) | 6 (14.3) |
Total bilirubin, >17.1 μmol/liter, no. (%) | 27 (9.1) | 4 (9.5) |
Uric acid, >416 umol/liter, no. (%) | 17 (5.7) | 2 (4.8) |
Creatinine, >133 μmol/liter, no. (%) | 13 (4.4) | 2 (4.8) |
Potassium | ||
median (range), mmol/liter | 3.76 (3.0–5.61) | 3.75 (3.18–4.57) |
<3.5 μmol/liter, no./total no. (%) | 32 (10.7) | 8 (19.0) |
Sodium, median (range), mmol/liter | 138 (132–143) | 138 (131–142) |
Erythrocyte sedimentation rate, >15 mm/hr, no. (%) | 79 (26.5) | 20 (47.6) |
C-reactive protein, >10 mg/liter — no. (%) | 117 (39.3) | 15 (35.7) |
Abnormalities on electrocardiogram, no./total no. (%) | 101/298 (33.9) | 16/42 (38.1) |
Sinus arrhythmia | 60/101 (59.4) | 11/16 (68.8) |
High left ventricular voltage | 27/101 (26.7) | 5/16 (31.3) |
Bundle branch block | 3/101 (3.0) | 1/16 (6.3) |
T-wave change | 7/101 (6.9) | 0 |
Ventricular premature contraction | 5/101 (5.0) | 1/16 (6.3) |
Abnormalities on chest radiograph and CT, no./total no. (%) | 108/298 (36.2) | 16/42 (38.1) |
Local patchy shadowing | 101/108 (93.5) | 15/16 (93.8) |
Ground-glass opacities | 3/108 (2.8) | 0 |
Pulmonary nodule | 6/108 (5.6) | 1/16 (6.3) |
Mediastinal lymphadenectasis | 5/108 (4.6) | 2/16 (12.5) |
Consolidation | 4/108 (3.7) | 1/16 (6.3) |
Involvement of left lung | 11/108 (10.2) | 1/16 (6.3) |
Involvement of right lung | 41/108 (38.0) | 4/16 (25.0) |
Involvement of both lungs | 56/108 (51.9) | 11/16 (68.8) |
